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ABSTRACT 
 
INTRODUCTION: Common iliac aneurysms are present in up to 40% of abdominal aortic 
aneurysms and frequently impair distal landing zones for endovascular aneurysm repair. Several 
techniques have been developed in order to overcome these issues, with different applications and 
conflicting results. Although long-term outcomes of hypogastric exclusion are favorable, the risks of 
pelvic ischemia and morbidity rates are high. We aim to review current hypogastric preservation 
strategies used in the endovascular treatment of aortoiliac aneurysms. 
 
EVIDENCE ACQUISITION: A thorough non-systematic review of the literature was conducted 
using PubMed/Medline. Forty-five articles were included, according to their scientific relevance and 
relation with the subject. 
 
EVIDENCE SYNTHESIS: The bell-bottom technique can be used in common iliac arteries with up 
to 24mm of diameter. Although apparently effective in the short-term, long-term durability is 
questionable with reported type 1b endoleak rates varying from 3,4-7,8% and high re-intervention 
rates reported. Iliac branches have better long-term outcomes, with 90,4% patency rates and 91,8% 
freedom from re-intervention at 10 years’ follow-up. Nonetheless, its widespread application is 
limited by complex anatomies and increased costs. Finally, parallel-graft techniques are an effective 
option for hostile anatomies unsuitable for other techniques. Endoleak due to gutter development 
remains the biggest limitation for its long-term durability and solid evidence regarding its application 
is still lacking.  
 
CONCLUSIONS: When determining the appropriate hypogastric preservation strategy, several 
factors should be considered. Anatomic criteria, life-expectancy as well as physical and sexual 
activity are the most important criteria. Procedure complexity and cost should also be accounted for. 
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INTRODUCTION 
 
Abdominal aortic aneurysm (AAA) is defined by an aortic diameter equal or superior to 30mm.
1
  Its 
estimated prevalence amongst men over the age of 50 is 5%
1
 and increases with age, so that it can 
reach 12,5% in men and 5,2% in women of 74 to 84 years of age.
2
 Although it may be clinically 
silent, its rupture is a medical emergency, with mortality rates of approximately 80%.
2, 3
 Elective 
treatment is therefore essential. 
In the earlier days, AAA’s were only manageable through open surgical repair. This was an effective 
treatment option, although associated with major complications, particularly in patients with higher 
co-morbidity rates. Later, with the advent of Endovascular Aneurysm Repair (EVAR), this paradigm 
shifted. Compared to open repair, EVAR significantly decreases blood loss, operative time, 
hospitalization time and morbidity rates,
4, 5
 broadening the treatment options for patients who would 
otherwise be deemed unsuitable.
6
 Nonetheless, this technique is not devoid of limitations, and re-
intervention rates are higher among these patients. Also, standard EVAR requires anatomic 
suitability to be implanted, and in only 50-70% of AAA’s that is observed.6 
In fact, in order to achieve proper aneurysm exclusion through EVAR, appropriate seal, both 
proximal and distal, is necessary, and although instructions for use (IFU’s) differ depending on the 
manufacturer, minimum landing zones of 10-15mm are consensual. Since approximately 20% of 
AAA’s extend to the iliac bifurcation7 and uni or bilateral iliac aneurysms may exist in up to 40% of 
AAA’s,8, 9 these conditions are frequently difficult to obtain. 
Inappropriate landing zones, in association with further aneurysmal degeneration of the iliac arteries 
after EVAR, can lead to endoleak or stent-graft migration,
10
 and therefore increase the risk of 
rupture. In order to overcome this issue, several techniques have been developed and implemented 
throughout the years. However, they present somewhat different applications and conflicting results. 
Through this article, we aim to review current internal iliac artery (IIA) preservation strategies used 
in the treatment of aortoiliac aneurysms. 
 
 
 
 
 
 
 
 
  
 
EVIDENCE ACQUISITION  
 
A thorough literature search was carried using Pubmed/Medline relative to articles published until 
September 2007 and using the following keywords: "iliac aneurysm", "iliac branch", "parallel graft" 
and "bell-bottom". From this research, one hundred and twenty-four articles were obtained. Only 
english-written articles published in the last ten years were accepted, and case reports were excluded 
from this review. In order to assure that all relevant articles were included, no other significant limits 
were imposed. From this selection, forty articles were excluded.  
All remaining eighty-four abstracts were accessed and seventeen were excluded for not being 
directly related with the subject, namely those approaching disease other than aortoiliac aneurysms 
or results on the proximal, rather than the distal sealing after EVAR. 
From the remaining sixty-seven, thirty-eight articles were included, according to the author’s 
preference and scientific relevance in the context of the proposed theme. A further manual search 
was conducted in order to further explore the epidemiology of AAA and technique results and seven 
articles were added. A total of forty-five articles were included (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
EVIDENCE SYNTHESIS  
 
DELIBERATE HYPOGASTRIC ARTERY OCCLUSION 
   
Deliberate occlusion of one or both of hypogastric arteries with distal seal in healthy external iliac 
artery (rather than in the common iliac artery), was the first technique developed to overcome sealing 
issues. Although current literature reports good long-term outcomes, high technical success and low 
endoleak rates,
11
 this technique is not devoid of complications. In fact, it is accompanied by a fairly 
worse clinical outcome, since up to 50%
7
 of the patients develop complications due to pelvic 
ischemia, with considerable impact in their quality of life and even risk of death. These pelvic 
ischemic symptoms are many, and vary in frequency and severity. The most common symptom 
reported is buttock claudication, affecting up to 28-42% of the patients, followed by vasculogenic 
impotence, reported in 17-24% of the cases.
12
 These are rather benign complications, although there 
are others such as bowel ischemia (3,4%), spinal cord ischemia (0,1-0,3%), sciatic nerve ischemia, 
sloughing of the scrotal skin, severe rest pain, paraplegia, and sacral tissue loss,
12-14
 which are 
considerably more severe and even potentially fatal.  
Over the years, changes to the standard procedure have been implemented in an attempt to reduce 
these complications. For instance, it was proposed that the interruption of the IIA should be 
performed as proximally as possible, in order to preserve the IIA bifurcation
15
 and seek a better 
conservation of collateral blood supply.
13
 Other techniques such as  flush coverage of the IIA origin
14
 
or even staged occlusion when bilateral intervention is necessary, were performed, although with no 
differences in the reported rate of complications. This is explained by the fact that hypogastric artery 
exclusion is an acute process, and therefore new ischemia-induced branch expansion is impossible. 
As a result, the presence or absence of symptoms highly depends on the pre-existing collateral 
circulation of the external iliac artery, profunda femoris arteries, mesenteric arcades and contralateral 
hypogastric artery.
16
  
It is also important to emphasize that patients with vascular disease and aneurysm formation, often 
simultaneously present with chronic embolization from mural thrombus of the aneurysm and/or 
concomitant atherosclerotic processes within the pelvic arteries. This may impair collateral branch 
irrigation, even if those branches do exist, making it difficult to predict which patients are more 
likely to develop complications and to what extent, solely based on the image study of the collateral 
circulation.
8
 Based on this, and even though long-term outcomes of hypogastric embolization are 
  
 
favorable, the risks of pelvic ischemia are too high, and preservative strategies aiming to preserve 
hypogastric flow, have been created. 
 
 
INTERNAL ILIAC ARTERY PRESERVATION STRATEGIES 
 
Over the years, several techniques have been developed in an attempt to both grant proper distal seal 
and preserve the hypogastric artery in aortoiliac aneurysms. 
Hybrid techniques were the first to be employed, with somewhat mixed results. These ranged from 
primary hypogastric artery bypasses to common iliac artery bandings for smaller aneurysms and, 
although effective, usually required  retroperitoneal incisions, therefore contradicting the concept of 
minimally invasive approach, which represents one of the main advantages of EVAR.
4
 Also, these 
hybrid approaches can be technically challenging, mainly in obese patients, narrow pelvises or larger 
aneurysms, as well as those submitted to previous pelvic surgery or radiation.
14
 
In order to overcome these limitations, several endovascular techniques have been developed, with 
conflicting applications and results. These vary from iliac branches to bell-bottom or parallel graft 
techniques, and will be considered in the following paragraphs. 
 
 
1. BELL-BOTTOM TECHNIQUE 
 
The bell-bottom or flared limb technique was first published in 1999,
17
 and employs flared limb 
devices in order to adequately obtain seal in a dilated common iliac artery (CIA). Both reversed 
extension limbs and aortic cuffs
17
 can be used, and since the largest available diameter of the flared 
limb stent graft is 28mm, it may be applied to CIA’s with a maximum diameter of 24mm.11 It is 
rather unexpensive and technically simple, making it a good treatment option readily available in all 
vascular centers.  
Nonetheless, and even though this technique represents a treatment option for numerous aneurysms, 
it is anatomically restrictive, demonstrating limited benefit for patients with larger aneurysms or IIA 
involvement.
7
 Also, long-term durability seems to be an issue, as  reported by some authors who 
consider that, since landing is obtained in an unhealthy vessel segment, continuous pressure to the 
ectasic or aneurysmal tissue occurs, eventually leading to further dilation of the distal landing zone, 
with endoleak and increased risk of rupture.
4
  
  
 
Several studies have been conducted on this matter and the reported results are controversial (Table 
I). Torsello et al studied the use of bell-bottom with flared limbs in CIA aneurysms with diameters 
between 20-30mm.
18
 The type 1b endoleak rate observed was 3,4%, with CIA diameter increases in 
4,4% of cases, from which the technique was deemed appropriate for CIA with up to 30mm of 
diameter.
18
 Alverez M. et al studied the short-term outcomes of the use of aortic extenders in 
aneurysms with a diameter up to 25 mm, with similar technical and clinical success rates as the ones 
reported in previous series.
17
 On the other hand, Telles et al, in a recent follow-up study, noted that 
after using the bell-bottom technique in patients with a CIA of 15 mm or more, further dilation 
occurred in 35,3% of the patients.
19
 In the same study, the reported endoleak rate was 17,6% (with 
7.8% type 1b and 9.8% type II) and re-intervention was needed in 15,7% of cases (more frequent in 
younger patients and those with more risk factors).
19
 On another study, Gray et al observed a 
significant difference in the type 1b endoleak incidence after bell-bottom in a group treated with iliac 
limbs of 20mm of diameter or more (18%), when compared to a group treated with regular limbs 
(4%). The first group of patients were 5,3 times more likely to develop a type 1b endoleak than the 
other group, regardless of the effectiveness of the initial seal.
20
 
In summary, the bell-bottom technique is a safe, feasible and unexpensive treatment option for 
ectasic CIAs or those that present small aneurysms. However, further aneurysmal degeneration 
seems to be associated with long-term type 1b endoleak and higher re-intervention rates. Long-term 
follow-up studies are necessary to assess the real advantages of this technique, in view of possible 
negative future outcomes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
2. ILIAC BRANCHES  
 
Iliac branches were first introduced in 2006, as an alternative to hypogastric embolization in the 
endovascular treatment of aortoiliac aneurysms.
21
 These are bifurcated grafts with a small lateral 
branch, and allow hypogastric artery preservation through a bridged covered stent. Unlike the bell-
bottom technique, iliac branches can be used in large aneurysms, although their implantation is more 
complex and certain anatomic restrictions are also present. 
 
2.1 - Anatomic considerations 
 
Standardized anatomical criteria for the use of iliac branches have not yet been established. 
Nonetheless, there are some known individual factors that should be considered, as they may 
increase the procedure’s technical difficulty and/or the risk for post-operative complications related 
to the graft patency. These include excessive iliac tortuosity, calcifications, intraluminal CIA 
thrombus or IIA stenosis.
4, 13
 Therefore, and although the devices should be applied according to 
their IFU’s, a case-by case evaluation of complex anatomy is necessary with appropriate pre-
operative planning.
22
 
The presence of IIA aneurysms also jeopardizes the effectiveness of iliac branches, and must be 
accounted for.
23
 When present, proper landing zone for the iliac component may not be available, 
therefore bearing high endoleak and re-intervention risks. Nonetheless, and although the IIA 
diameter is often one of the most prominent adverse anatomical features for iliac branch 
deployment,
12, 24
 it may not always be an exclusion factor. In fact, treatment of IIA aneurysms with 
iliac branches extending to the superior gluteal artery has been attempted with satisfactory results, as 
reported by M. Noel-Lamy et al in a series of 15 patients.
25
 Despite effective, these procedures are 
usually more complex and therefore more prone to complications. 
 
2.2 - Technical and clinical outcomes 
 
Since iliac branches were first introduced, a significant increase in both technical success and 
patency rates were observed (Table II). Nowadays, technical success ranges from 85% to 96,3% 
11
 
and even reaches 100% in smaller series.
7, 11, 13
 This reflects not only a general improvement of the 
devices, but also, better patient selection as well as an improvement in procedure-related learning 
curve.
8, 11
 
  
 
Regarding clinical outcomes (Table II), current evidence reports 5-year patency rates of 88%-
91,4%,
11, 26
 with freedom from re-intervention of 81,3%.
26
 Branch graft occlusion rates are of 1,2-
12,2%
11, 13
, which may or may not be symptomatic, as reported by A. Karthikesalingam et al, who, in 
a series 196 iliac branches with a 12,2% occlusion rate, demonstrated that only half of these 
developed symptomatic buttock claudication.
13
 
Similarly to conventional EVAR procedures, endoleak remains a great concern in iliac branch 
implantations. Type 2 endoleak is the most common, with rates fluctuating between 0 to 15.8%.
7
 
Type 3 endoleak is less frequent, affecting up to 7,14% of the patients,
8
 although, unlike type 2, 
requires a more active and immediate treatment to prevent aneurysm rupture as a consequence of its 
continuous pressurization.
8, 27
 Type 1 endoleak may also occur in up to 5%
28
 and requires immediate 
intervention as well.
29
  
Unlike the bell-bottom technique, there are long-term follow-up studies available regarding iliac 
branches, which generally report favorable outcomes for this technique. 
Jongsma et al studied the outcomes of 140 patients throughout 11 years and reported a technical 
success of 96,9%, with considerable sac regression obtained in 51,3% of the patients. On the other 
hand, sac enlargement was observed in 13,1% patients, half of them due to type 1 or type 3 
endoleaks. IIA branch occlusion occurred in 9,3% patients, of which, only 3,7% developed buttock 
claudication. Freedom from re-intervention was 75,9% after 5 years.
28
 
G. Simonte et al, in a similar study, analyzed 149 patients throughout 10 years and described a 
97,5% technical success rate, with 90,4% patency after 10 years and freedom from re-intervention of 
94% and 91,8% after 5 and 10 years, respectively.
23
 
Donas et al, in the largest series available (n=575) reported similar findings, with 85,7% overall 
freedom from re-intervention for type 1 endoleak or occlusions.
30
 
Although this technique is complex and requires certain endovascular skills, there seems to be no 
significant differences in procedure time, contrast use, technical success or early deaths when 
compared with the bell-bottom technique, as reported by Vernizi et al. On the other hand, the iliac 
branch group had much superior results regarding endoleak rates (4% vs 19%) and pelvic ischemic 
symptoms (4% vs 22%) when comparing with its counterpart.
31
 
 
 
3. PARALLEL GRAFT TECHNIQUES 
 
Parallel graft techniques such as sandwich-graft, double-barrel, internal iliac snorkel or chimney 
techniques, have also been proposed as an alternative for the treatment of complex aortoiliac or 
  
 
isolated CIA aneurysms.
11, 32
 The most commonly used technique in this setting is the internal iliac 
snorkel, which consists in the implantation of a covered stent in the IIA, in a parallel configuration 
with the main graft, granting IIA perfusion in a retrograde fashion.
33
 
Initially projected as a bailout solution for emergent situations or inadverted intraoperative vessel 
coverage, parallel graft techniques are now performed as elective procedures in certain cases with 
complex anatomy.
34
 In fact, even though bell-bottom and iliac branches expanded the endovascular 
options in aortoiliac aneurysms, there are several anatomies in which these techniques remain 
inadequate.
12
 Parallel graft techniques emerged as an effective treatment option for these patients that 
would otherwise be deemed unsuitable for endovascular repair.  
Although an off-label technique, with sparse literature regarding its application in aortoiliac 
aneurysms, it appears to be safe and feasible, with encouraging short and mid-term outcomes (Table 
III). In fact, both Wu et al, in a series of 14 patients using the Crossover Chimney Technique,
35
 and 
Lobato and Camacho-Lobato, in a series of 40 patients treated with the Sandwich Technique,
36
 
reported similar midterm results. Technical success rate was 100% and primary patency rates of 
92,8% and 93,8%, respectively. Furthermore, in the second study, a decrease in iliac aneurysm 
diameter was found in 34,8% of patients, with no symptomatic occlusions described. All of the 
patients considered for the studies showed complex anatomy and did not fulfill the requirements for 
standard EVAR technique. Identical outcomes were reported by C.S. Lim et al, with 100% technical 
success rate, a primary patency rate of 90,5%, and significant post-operative aneurysm reduction 
(>5mm) in 66,7% of patients.
32
  
Despite effective, the main restrain of this technique remains the post-procedure “gutter” 
development. It occurs when there is a loss of apposition between the parallel stent-grafts themselves 
and the vessel wall.
37
 This can lead to a type 1 endoleak due to the interspace created between grafts, 
and is potentially difficult to treat.
38
 Massmann et al, in a series of 41 patients treated with sandwich-
technique to preserve hypogastric flow, described post-procedure gutter-endoleaks
20
 in 6,5% of 
patients. Further studies are therefore required regarding long-term outcomes of this technique. 
 
 
DISCUSSION 
 
Taking into account the morbidity and even mortality associated with IIA embolization prior to 
EVAR, several alternatives to IIA sacrifice have emerged in recent years. These are especially 
important in patients expected to have higher symptom severity with hypogastric embolization, and 
several factors should be considered when assessing them. 
  
 
In fact, the severity of symptoms is determined not only by the collateral supply existent, but also the 
end organ demand in the vascular territory of the IIA that would be occluded, and the baseline blood 
supply available. Therefore, patients with higher demand, such as younger and more active patients, 
as well as those whose blood supply is already diminished due to reduced cardiac output, are more 
likely to develop claudication upon IIA occlusion.
13
 In addition, one must remember that the 
hypogastric arteries contribute to the collateral pathway responsible for spinal cord perfusion. 
Therefore, patients planned to undergo endovascular repair of more proximal aortic segments, in 
which intercostal branch re-implantation is not feasible,
20
 as well as those with simultaneous thoraco-
abdominal aneurysms, rely on the iliac circulation for spinal cord perfusion, which must be preserved 
at all costs. 
4
  
In order to achieve this, several techniques have been developed, although with different applications 
and conflicting results. This makes it impossible to clearly identify one technique as superior over 
the others, although recommendations can be issued on which technique to use in specific settings. 
 
 
a) Bell-Bottom 
 
Regarding endovascular approach to aortoiliac aneurysms, the bell-bottom technique offers a very 
interesting choice of treatment, both economically and result wise. In a comparative study between 
bell-bottom and hypogastric exclusion prior to EVAR, Naughton et al observed a significant lower 
combined incidence of complications in the bell-bottom group (22% vs 49%). Although no 
significant differences regarding total re-intervention rates were found between the techniques, 
considering that bell-bottom preserves pelvic flow, it was considered to be preferable upon 
availability.
15
  
Despite the up mentioned results, one must recall that bell-bottom is limited by several anatomic 
factors. Regarding this, the same study by Naughton et al issued some recommendations, considering 
it as the preferable treatment option when CIA diameter in the sealing segment was inferior to 
25mm. When a CIA bifurcation with 25mm or more, significant thrombus in the CIA or IIA 
aneurysm were present, hypogastric occlusion should be employed, despite higher risk of 
complications.
15
  
Nowadays, with the development of alternative hypogastric preservation strategies, these indications 
have changed. Nonetheless, CIA diameter continues to be a major factor to be considered regarding 
recommendation for this method. Therefore, the authors consider the bell-bottom technique as an 
  
 
effective option in patients with shorter life expectancy, with CIA with < 25mm in the sealing 
segment, and no internal iliac artery aneurysm. 
 
 
b) Iliac branches 
 
As previously discussed, iliac branches represent an effective treatment option. However, these 
devices have strict anatomic criteria, which can limit its applicability. Tielliu et al, in a series of 59 
patients,  reported that only 52% of patients with aortoiliac or isolated iliac aneurysms were 
morphologically suited for iliac branch.
39
 On a similar study, Pearce et al studied the anatomic 
suitability of 99 patients for two different types of devices and, comparing the patients from both 
groups, only 35,4% of patients would be anatomically suited for treatment with any of the devices.
12
 
In a similar study by Karthikesalingam et al, only 29% of the internal iliac arteries were fully 
compatible for the devices.
24
 
This low morphological suitability for iliac branch deployment has implications and suggests that the 
short or long-term results of iliac branch may be underestimated, due to an incorrect application of 
the device, resulting in increased endoleak and failure rates.
26
 
Anatomical indications for iliac branches vary according to different manufacturers and types of 
devices employed. Therefore, respective IFUs for each device should be evaluated when accessing 
each patient’s applicability (Table IV). Nonetheless, as previously determined, the CIA diameter is 
one of the anatomic key factors, especially in the scope of endovascular distal fixation. 
Due to the great short and long-term results reported, iliac branches are considered as the first-line 
approach for CIA aneurysms with >30mm of diameter, with or without concomitant AAA.
17,23
 
Nonetheless, when considering CIA with shorter diameters, particularly when CIA < 25mm, a grey 
zone exists regarding the best technique to employ. The authors recommend that if a patient presents 
low life expectancy or if iliac branch has previously failed, bell-bottom should be performed; in the 
remaining cases, iliac branch should be the treatment of choice 
10
. 
Also, presence of factors that increase procedure’s technical difficulty and/or the risk for post 
interventional complications related to the graft patency should weigh in this decision. These are 
variable and include excessive iliac tortuosity, calcifications, IIA aneurysm or stenosis, poor runoff, 
sharp aortic bifurcation, intraluminal CIA thrombus, severe EIA kinking, or wide angle (>50º) of the 
IIA branch and IIA artery 
4, 8, 13
. In the presence of multiple of these factors, the increased anatomic 
complexity would tilt the choice towards another technique. 
  
 
In a cost-effectiveness perspective, younger, more active patients or those at higher risk of 
symptomatic pelvic ischemia (e.g thoracoabdominal endovascular repairs), would benefit the most 
from iliac branches.
13
 However, different studies recommend its use, not only in these patients, but in 
all cases of AAA with extent to the iliac bifurcation, as long as favorable anatomy exists.
7
 
 
 
c) Parallel-grafts 
 
Despite the lack of solid evidence concerning this technique, it has gained popularity in recent years. 
Some authors consider it only for emergent approaches or in poor-surgical-risk patients
40
. Others 
advocate it should always exist as an option when dealing with complex aortic disease, since it has 
proven to be safe and effective in mid-term follow up studies.
34
 Nonetheless, long-term follow-up 
studies are still lacking, and no information regarding late gutter development or graft behavior after 
implantation is available. 
Based on this, the authors consider this an exceptional technique that should be part of any vascular 
surgeon’s armamentarium. Nonetheless, due to the lack of long-term follow-up studies, we 
recommend that it should only be used as a bailout treatment option, when dealing with unsuitable 
anatomies for iliac branch or in emergency situations. 
 
All in all, there are several techniques to be considered when treating aortoiliac aneurysms, and 
several factors should be measured upon the choice of the best treatment option. As pointed by 
Huilgol et al, 
16
 factors such as patient’s life expectancy, their level of physical and sexual activity 
and the expected risk of serious ischemic complications from IIA embolization, should be assessed 
when choosing a treatment technique. Specific aneurysm morphology, the risks of a potentially 
longer procedure and associated larger contrast volumes, as well as the financial cost of the 
procedure and the endovascular skills required, should also be considered. 
 
 
CONCLUSION 
 
When treating aortoiliac aneurysms, endovascular options may be impaired by improper distal 
landing zones. Deliberate hypogastric exclusion has proved effective, although evidence reports high 
morbidity rates due to pelvic ischemia. IIA preservation is therefore important to be considered and 
the bell-bottom technique, iliac branches and parallel-graft techniques are clinically more 
  
 
advantageous. Although none has proved benefits over the others, each of these techniques presents 
valid recommendations (Table V). 
Iliac branches are the most widespread, showcasing more enticing long-term results. However, 
several anatomic features limit their applicability and its use in hostile anatomy may result in a 
decrease of its efficacy and durability. In some cases, the bell-bottom technique may be a viable 
option if common iliac diameter is not over 24 mm. Nonetheless, their long-term durability and 
higher re-intervention rates should be considered before implantation. Finally, parallel-graft 
techniques broadened the treatment options in complex anatomies unsuitable for other approaches, 
particularly in emergency situations when of-the-shelf grafts are not available. Although effective in 
the short-term, long-term results are still missing. 
Correct patient selection is crucial for the effectiveness of the mentioned techniques. The importance 
of defining specific anatomic criteria for each method as well as considering individual cases of life 
expectancy and emergency setting upon treatment choice must not be forgotten. Further long-term 
studies are needed for that stratification and for the evaluation of long-term results. 
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TABLES
Authors 
(year) 
N 
Mean 
CIA 
Diameter 
(range) 
 
Mean 
Follow-Up 
Time 
Technical 
Sucess 
Aneurysm Sac 
Regression 
Aneurysm Sac 
Dilation 
Freedom from 
Secondary 
Intervention 
Endoleak Rate 
Torsello et 
al
18
 
(2010) 
89 
22.1 ± 3.0 
mm 
(20-30mm) 
56.5 ± 2.1 
months 
97.8% Not significant 4.4% 
91.6% at 5 
years 
Type I - 3.4% 
Type II - 2.2% 
Naughton 
et al
15
 
(2012) 
166 
20 mm 
(20-28 mm) 
22 months 
(9-38) 
- - - 89% - 
Alverez 
M. et al
17
 
(2013) 
19 
20 mm 
(18-25mm) 
35 months 94.7% Not significant - 
72.6% at 4 
years 
Type II – 21% 
Telles et 
al
19
 
(2016) 
38 
21mm ± 4 
mm 
(15-32mm) 
25.8 ± 14.9 
months 
- 
64.7% 
unchanged or 
reduced up to 
20% 
35.3% 
84.3% at 
median follow-
up time 
Type Ib – 7.8% 
Type II – 9.8% 
Gray et 
al
20
 
(2017) 
128 14mm 53 months - - - - 
Type Ib – 18% 
in CIA> 20mm 
and 3.9% in 
CIA< 20mm 
Table I - Clinical results of hypogastric preservation with the bell-bottom technique. 
  
 
Authors 
(year) 
N 
Mean 
CIA 
Diameter 
(range) 
Mean 
Follow-Up 
Technical 
Sucess 
Graft 
Patency 
Branch 
Occlusi
on 
Aneurysm Sac 
Regression 
Aneurysm Sac 
Dilation 
Buttock 
Claudication 
Freedom 
from 
secondary 
Intervention 
Endoleak Rate 
Dias et al
22
 
(2008) 
22 
34 mm 
(27-41) 
20 months 
(8-31) 
91% 74% 27% 
56% with CT-
FU 1 year 
0% - 82% 
Type II – 9% 
Type III- 
4,5% 
Vernizi et al
31
 
(2009) 
32 
40.2 ± 7.9 
mm 
9.8 months 
(1-24) 
94% - 0% 30% - - 84% - 
Tielliu et al
41
 
(2009) 
27 - 
16 ± 14 
months 
96% - - - - - - - 
A. Karthikesalingam 
et al
13
 
(2010) 
196 
(9 
series) 
31,5-
39mm 
(15-78mm) 
6-24 
months 
85-100% - 12.2% - - 6,63% - 
Type I-0,51% 
Type III-
1,02% 
Pua et al
8
 
(2011) 
14 
39mm (34-
57mm) 
18.7 
months (6-
35 mo.) 
86% 100% - - 7,14% 0% 92,86% 
Type II- 
14,3% 
Type III- 
7,14% 
Parlani et al
26
 (2012) 100 
40 mm 
(35-44) 
17 months 
(1-60) 
95% 
91,4% 
at 5 
years 
- 72% 4% 4% 
81.4% at 5 
years 
Type Ib- 2% 
Type III- 1% 
Wong et al
42
 
(2013) 
130 
34.6 and 
31.2  
20.3 
months 
(1-72) 
94% 
81.6% 
at 5 
years 
- 67% 0% - - - 
Table II - Clinical results of hypogastric preservation with iliac branches 
  
 
Authors (year) N 
Mean 
CIA 
Diameter 
(range) 
 
Mean 
Follow-Up 
Technical 
Sucess 
Graft 
Patency 
Branch 
Occlusi
on 
Aneurysm Sac 
Regression 
Aneurysm Sac 
Dilation 
Buttock 
Claudication 
Freedom 
from 
secondary 
Intervention 
Endoleak Rate 
Férnandez-Alonso 
et al
7
 (2013) 
9 
34.8mm 
(29-50mm) 
14.7 
months 
(9-29 mo.) 
100% 100% - - - 0% - 
Type II – 
15,8% 
Jongsma 
et al
28
 
(2017) 
140 
37.0-
41.4mm 
26.6 ± 24.1 
months 
96.9% - 9.3% 51.3% 13.1% 4,29% - 
Type Ib- 5% 
Type III- 
2,14% 
G. Simonte 
et al
23
 
(2017) 
149 
37.0 ± 8.1 
mm 
44.2 ± 35.1 
months 
97.5% 
90.4% 
at 10 
years 
- - - - 
91.8% at 9 
years 
- 
Donas et al
30
 
(2017) 
575 
L: 30.1 ± 
11.9 mm 
and 
R: 32.6 ± 
12.3 mm 
32.6 ± 9.9 
months 
97.6% 94.8% - - - - 91,1% Type I- 4,9% 
Table II – Continuation  
  
 
 
Authors 
(year) 
N 
Mean 
CIA 
Diameter 
(range) 
 
Mean 
Follow-Up 
Technical 
Sucess 
Graft 
Patency 
Branch 
Occlusion 
Aneurysm Sac 
Regression 
Aneurysm Sac 
Dilation 
Buttock 
Claudication 
Freedom from 
secondary 
Intervention 
Endoleak Rate 
Wu et al
35
 
(2015) 
14 
36 ± 4mm 
(n=7) 
54 ± 22mm 
(n=6) 
12mm (n=1) 
14.3 
months (6-
21) 
100% 92,8% 7% 21,4% 0% 14,3% - 
Type I or III- 
0% 
Type II- 21,4% 
at follow-up 
Lobato 
and 
Camacho-
Lobato
36
 
(2013) 
40 
56.2 ± 
6.4mm 
(n=33) 
30.6 ± 
7.1mm 
(n=6) 
57mm (n=1) 
12 months 
(6-30) 
100% 93.8% - 34,8% 2,2% 0% 100% 
Type I or III- 
0% 
Type II- 2,5% 
C.S.Lim 
et al
32
 
(2016) 
21 
L: 40.0 mm 
(24-81) 
R: 37.6 mm 
(35-87) 
17.2 
months (5-
40) 
100% 90.5% - 66.7% 0% - - - 
Massman
n et al
38
 
(2016) 
 
24 43 ± 15 mm 
15.0 
months (1–
40) 
100% 
84.2% in 
1 year 
- 61.5% 0% - - Type Ib- 6.5% 
Table III – Clinical results of hypogastric preservation with parallel-grafts.  
  
 
 
 
 
  
 
 
GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE)
43
: 
- Adequate iliac / femoral access 
- CIA diameter ≥ 17 mm at the proximal implantation zone of the IBE 
- EIA treatment 
- Length ≥ 10 mm 
- Diameter range of 6.5 – 25 mm 
- IIA treatment 
- Length ≥ 10 mm 
- Diameter range of 6.5 – 13.5 mm 
- Adequate length from the lowest major renal artery to the internal iliac artery to 
accommodate the total endoprosthesis length, calculated by adding the minimum lengths 
of required components, taking into account appropriate overlaps between components 
COOK® Zenith® Branch Iliac Endovascular Graft (IBD)
44
: 
- Adequate iliac/femoral access compatible with a 20 French (7.7 mm OD) introduction 
system 
- CIA diameter ≥ 16 mm adjacent to the branch 
- Non-aneurysmal EIA fixation segment distal to the aneurysm 
- Length ≥ 20 mm 
- Diameter range of 8-11mm 
- Non-aneurysmal IIA segment distal to the aneurysm 
- Length ≥ 10 mm (with 20-30 mm being preferred) 
- Diameter acceptable for proper sealing. 
JOTEC® E-liac ® stent graft system
45
: 
The stent graft is available in the following lengths and diameters, permitting users to select the 
product according to the specific indication and the patient’s vascular anatomy: 
- Total length: 97-121mm 
- Proximal 
- Length: 53/65mm 
- Diameter: 14/16/18 mm 
- Distal 
- Length: 44/56mm 
- Diameter: 10/12/14mm 
Table IV – Manufacter’s Instructions For Use (IFUs) for current commercially available iliac branches. 
  
 
 
 
  
 
 
Bell-Bottom: 
Patients with CIA diameter ≤24mm with: 
 Lower Life Expectancy and/or less active patients 
 Absence of significant thrombus in the CIA/IIA 
 Iliac Branch has previously failed 
 
Iliac Branches: 
Gold-standard treatment option in patients with CIA diameter >30mm 
 Also indicated for smaller CIAs as long as other anatomic features are met and 
particularly if concomitant AAA is present 
 
Should be especially considered in: 
 Higher life expectancy and/or younger and more active patients 
 Higher risk of symptomatic pelvic ischemia 
- Thoraco-abdominal endovascular repairs 
- Contralateral iliac occlusion 
 
Parallel-Grafts: 
 Emergency situations 
 Higher complexity anatomies unsuitable for other techniques 
Table V – Recommendations for the use of different internal iliac artery preservation strategies in the 
endovascular repair of aortoiliac aneurysms. 
  
 
FIGURES 
Figure 1- Flowchart demonstrating Evidence Acquisition. 
 
 
Search with the following 
Keywords:  
"iliac aneurysm", "iliac branch", 
"parallel graft" and "bell-bottom" 
124 articles 
57 articles excluded 
21 previous to 2007 
19 Case Reports 
7 referring to 
pathology other than 
aortoiliac aneurysm 
10 referring to 
Proximal EVAR 
Sealing 
67 articles 
38 articles 
29 articles excluded 
after full-read  
45 articles 
7 articles added 
following manual 
search  
14 referring to 
technique employment 
in the complication 
management of 
previous endovascular 
treatment  
5 referring to 
custom-made stent-
grafts 
10 focusing on 
mechanical or 
technical aspects of 
the techniques 
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